Reduced myocardial perfusion is common among subjects with ischemia and no obstructive coronary artery disease and heart failure with preserved ejection fraction: a report from the WISE-CVD continuation study

Abstract

Aim: Women with evidence of ischemia and no obstructive coronary artery disease (INOCA) have an increased risk of major adverse cardiac events, including heart failure with preserved ejection fraction (HFpEF). To investigate potential links between INOCA and HFpEF, we examined pathophysiological findings present in both INOCA and HFpEF.

Methods: We performed adenosine stress cardiac magnetic resonance imaging (CMRI) in 56 participants, including 35 women with suspected INOCA, 13 women with HFpEF, and 8 reference control women. Myocardial perfusion imaging was performed at rest and with vasodilator stress with intravenous adenosine. Myocardial perfusion reserve index was quantified as the ratio of the upslope of increase in myocardial contrast at stress vs. rest. All CMRI measures were quantified using CVI42 software (Circle Cardiovascular Imaging Inc). Statistical analysis was performed using linear regression models, Fisher’s exact tests, ANOVA, or Kruskal-Wallis tests.

Results: Age (P = 0.007), Body surface area (0.05) were higher in the HFpEF group. Left ventricular ejection fraction (P = 0.02) was lower among the INOCA and HFpEF groups than reference controls after age adjustment. In addition, there was a graded reduction in myocardial perfusion reserve index in HFpEF vs. INOCA vs. reference controls (1.5 ± 0.3, 1.8 ± 0.3, 1.9 ± 0.3, P = 0.02), which was attenuated with age-adjustment.

Conclusion: Reduced myocardial perfusion reserve appears to be a common pathophysiologic feature in INOCA and HFpEF patients.

Keywords

Non-obstructive coronary artery disease / cardiac magnetic resonance imaging / coronary microvascular dysfunction / heart failure with preserved ejection fraction

References

[1] AlBadri A,Wei J.Inflammatory biomarkers as predictors of heart failure in women without obstructive coronary artery disease: a report from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).PLoS One2017;12:e0177684 PMCID:PMC5438124

[2] Merz CN, Pepine CJ, Walsh MN, Fleg JL. Ischemia and no obstructive coronary artery disease (INOCA): developing evidence-based therapies and research agenda for the next decade.Circulation2017;135:1075-92 PMCID:PMC5385930

[3] Bakir M,Jones E.Heart failure hospitalization in women with signs and symptoms of ischemia: a report from the women's ischemia syndrome evaluation study.Int J Cardiol2016;223:936-9 PMCID:PMC8312227

[4] Taqueti VR,Shah AM.Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction.Eur Heart J2018;39:840-9 PMCID:PMC5939665

[5] Thomson LE,Agarwal M.Cardiac magnetic resonance myocardial perfusion reserve index is reduced in women with coronary microvascular dysfunction. A national heart, lung, and blood institute-sponsored study from the women's ischemia syndrome evaluation.Circ Cardiovasc Imaging2015;8:e002481 PMCID:PMC4375783

[6] Nelson MD,Shaw JL.Myocardial tissue deformation is reduced in subjects with coronary microvascular dysfunction but not rescued by treatment with ranolazine.Clin Cardiol2017;40:300-6

[7] Nelson MD,Bairey Merz CN.Coronary microvascular dysfunction and heart failure with preserved ejection fraction as female-pattern cardiovascular disease: the chicken or the egg?.Eur Heart J2018;39:850-2 PMCID:PMC5939623

[8] Wei J,Darounian N.Myocardial scar is prevalent and associated with subclinical myocardial dysfunction in women with suspected ischemia but no obstructive coronary artery disease: from the women's ischemia syndrome evaluation-coronary vascular dysfunction study.Circulation2018;137:874-6 PMCID:PMC5823279

[9] Wei J,Johnson BD.Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.JACC Cardiovasc Interv2012;5:646-53 PMCID:PMC3417766

[10] Amsterdam EA,Brindis RG.2014 AHA/ACC guideline for the management of patients with non-st-elevation acute coronary syndromes: a report of the American college of cardiology/american heart association task force on practice guidelines.J Am Coll Cardiol2014;64:e139-228

[11] Ponikowski P,Anker SD.ESC Scientific Document Group2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.Eur Heart J2016;37:2129-200

[12] Shah SJ,Svedlund S.Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF.Eur Heart J2018;39:3439-50 PMCID:PMC6927847

[13] Elgendy IY.Heart failure with preserved ejection fraction: is ischemia due to coronary microvascular dysfunction a mechanistic factor?.Am J Med2019;132:692-7 PMCID:PMC7722793

[14] Wei J,Sharif B,Bairey Merz CN.Why do we care about coronary microvascular dysfunction and heart failure with preserved ejection fraction: addressing knowledge gaps for evidence-based guidelines.Eur Heart J2018;39:3451-3 PMCID:PMC6927824

[15] Hoang K,Gardin JM.LV mass as a predictor of CVD events in older adults with and without metabolic syndrome and diabetes.JACC Cardiovasc Imaging2015;8:1007-15 PMCID:PMC5845438

[16] Shah SJ.Sedentary lifestyle and the risk for HFpEF: are "huff-puff health clubs" the answer?.J Am Coll Cardiol2017;69:1143-6

[17] Agarwal M,Mehta PK.Cardiac risk factors and myocardial perfusion reserve in women with microvascular coronary dysfunction.Cardiovasc Diagn Ther2013;3:146-52 PMCID:PMC3839214

[18] Srivaratharajah K,deKemp R.Reduced myocardial flow in heart failure patients with preserved ejection fraction.Circ Heart Fail2016;9:e002562

[19] Wang L,Jacobs DR Jr,Folsom AR.Coronary risk factors and myocardial perfusion in asymptomatic adults: the Multi-Ethnic Study of Atherosclerosis (MESA).J Am Coll Cardiol2006;47:565-72